| 000 | 01773 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514005916.0 | ||
| 264 | 0 | _c20010906 | |
| 008 | 200109s 0 0 fre d | ||
| 022 | _a1278-3218 | ||
| 024 | 7 |
_a10.1016/s1278-3218(01)00111-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBelkacémi, Y | |
| 245 | 0 | 0 |
_a[Radiation-induced cataract: physiopathologic, radiobiologic and clinical aspects]. _h[electronic resource] |
| 260 |
_bCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique _cAug 2001 |
||
| 300 |
_a397-412 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadverse effects |
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aAntioxidants _xmetabolism |
| 650 | 0 | 4 |
_aCataract _xetiology |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose Fractionation, Radiation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 |
_aHeparin _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLinear Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRadiation-Protective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aRadiotherapy _xadverse effects |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 |
_aSjogren's Syndrome _xetiology |
| 650 | 0 | 4 | _aSteroids |
| 650 | 0 | 4 |
_aWhole-Body Irradiation _xadverse effects |
| 700 | 1 | _aTouboul, E | |
| 700 | 1 | _aMéric, J B | |
| 700 | 1 | _aRat, P | |
| 700 | 1 | _aWarnet, J M | |
| 773 | 0 |
_tCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique _gvol. 5 _gno. 4 _gp. 397-412 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1278-3218(01)00111-1 _zAvailable from publisher's website |
| 999 |
_c11449398 _d11449398 |
||